高级检索
当前位置: 首页 > 详情页

Chinese expert consensus on multidisciplinary diagnosis and treatment of pancreatic neuroendocrine liver metastases

文献详情

资源类型:
WOS体系:

收录情况: ◇ ESCI ◇ 中华系列

机构: [1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Canc Hosp, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China [2]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr Canc Hosp, Dept Diagnost Radiol, Beijing, Peoples R China [3]Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Dept Pathol,Canc Hosp, Beijing, Peoples R China [4]Chinese Acad Med Sci & Peking Union Med Coll, Dept Endoscopy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China [5]Peking Union Med Coll Hosp, Dept Med Oncol, Beijing, Peoples R China [6]Sichuan Univ, West China Hosp, Canc Ctr, Dept Abdominal Oncol, Chengdu, Peoples R China [7]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,Natl Canc Ctr, Beijing, Peoples R China [8]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing, Peoples R China [9]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Beijing Key Lab Mol Targeted Diag & Therapy Nucl M, Dept Nucl Med, Beijing, Peoples R China [10]Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai, Peoples R China [11]Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Beijing, Peoples R China [12]Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China [13]China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China [14]Peking Univ Third Hosp, Peking Univ Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing, Peoples R China [15]Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Peoples R China [16]Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Key Lab Hepatosplen Surg,Minist Educ, Harbin, Peoples R China [17]China Japan Friendship Hosp, Dept Integrat Oncol, Beijing, Peoples R China [18]Nanjing Med Univ, Nanjing Hosp 1, Dept Nucl Med, Nanjing, Peoples R China [19]Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing, Peoples R China [20]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Gen Surg, Beijing, Peoples R China [21]Peking Univ Third Hosp, Dept Gen Surg, Beijing, Peoples R China [22]Fifth Med Ctr PLA Gen Hosp, Dept Gastrointestinal Oncol, Beijing, Peoples R China [23]Hebei Med Univ, Hosp 4, Dept Gastroenterol, Shijiazhuang, Peoples R China [24]Peking Univ, Dept Nucl Med, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing, Peoples R China [25]Chinese Acad Med Sci & Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Pathol, Beijing, Peoples R China [26]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Pancreat & Gastr Surg,Natl Canc Ctr, Beijing 100021, Peoples R China [27]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,State Key Lab Mol Oncol,Na, Beijing 100021, Peoples R China
出处:
ISSN:

关键词: pancreatic neuroendocrine neoplasms liver metastases clinical diagnosis treatment

摘要:
Many management strategies are available for pancreatic neuroendocrine neoplasms with liver metastases. However, a lack of biological, molecular, and genomic information and an absence of data from rigorous trials limit the validity of these strategies. This review presents the viewpoints from an international conference consisting of several expert working groups. The working groups reviewed a series of questions of particular interest to clinicians taking care of patients with pancreatic neuroendocrine neoplasms with liver metastases by reviewing the existing management strategies and literature, evaluating the evidence on which management decisions were based, developing internationally acceptable recommendations for clinical practice, and making recommendations for clinical and research endeavors. The review for each question will be followed by recommendations from the panel.

基金:
语种:
被引次数:
WOS:
中科院分区:
出版当年[2023]版:
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 胃肠肝病学
JCR分区:
出版当年[2023]版:
Q4 GASTROENTEROLOGY & HEPATOLOGY
最新[2024]版:
Q4 GASTROENTEROLOGY & HEPATOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版] 出版后一年[2024版]

第一作者:
第一作者机构: [1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Canc Hosp, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [7]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,Natl Canc Ctr, Beijing, Peoples R China [27]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,State Key Lab Mol Oncol,Na, Beijing 100021, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42313 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号